This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Martin Pharmaceuticals, Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Sven M Jacobson: Innovator in Ascites Treatment
Introduction
Sven M Jacobson is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the treatment of ascites. With a total of 2 patents to his name, Jacobson's work focuses on innovative methods that improve patient outcomes.
Latest Patents
Jacobson's latest patents include groundbreaking methods for treating ascites. The first patent details a treatment approach for refractory ascites using an orally bioavailable prodrug of dopamine, specifically docarpamine. This invention emphasizes intermittent dosing, alternating between treatment and off-treatment periods. The second patent also addresses the treatment of ascites with the same prodrug, targeting patients who are on high doses of diuretics prior to treatment. The invention is particularly relevant for patients suffering from liver cirrhosis due to alcohol or non-alcoholic fatty liver disease.
Career Highlights
Sven M Jacobson is currently associated with Martin Pharmaceuticals, Inc., where he continues to develop innovative treatments. His work has the potential to significantly impact the management of ascites, particularly in patients who have not responded to traditional therapies.
Collaborations
Jacobson collaborates with Thomas MacAllister, contributing to the advancement of medical treatments through shared expertise and innovative ideas.
Conclusion
Sven M Jacobson is a pioneering inventor whose work in the treatment of ascites showcases his commitment to improving patient care. His innovative approaches and collaborations are paving the way for advancements in medical treatments.